OSIR
Goldman Sachs’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-272,227
| Closed | -$5.17M | – | 4425 |
|
|
2019
Q1 | $5.17M | Buy |
272,227
+260,246
| +2,172% | +$4.94M | ﹤0.01% | 2412 |
|
|
2018
Q4 | $162K | Buy |
+11,981
| New | +$162K | ﹤0.01% | 3794 |
|
|
2016
Q4 | – | Sell |
-33,927
| Closed | -$168K | – | 4730 |
|
|
2016
Q3 | $168K | Sell |
33,927
-16,494
| -33% | -$81.7K | ﹤0.01% | 4001 |
|
|
2016
Q2 | $257K | Sell |
50,421
-4,913
| -9% | -$25K | ﹤0.01% | 3715 |
|
|
2016
Q1 | $316K | Buy |
55,334
+8,363
| +18% | +$47.8K | ﹤0.01% | 3518 |
|
|
2015
Q4 | $488K | Sell |
46,971
-3,062
| -6% | -$31.8K | ﹤0.01% | 3261 |
|
|
2015
Q3 | $924K | Buy |
+50,033
| New | +$924K | ﹤0.01% | 2952 |
|
|
2014
Q4 | – | Sell |
-13,276
| Closed | -$167K | – | 4865 |
|
|
2014
Q3 | $167K | Buy |
+13,276
| New | +$167K | ﹤0.01% | 4051 |
|
|
2014
Q1 | – | Sell |
-13,975
| Closed | -$225K | – | 4527 |
|
|
2013
Q4 | $225K | Buy |
13,975
+1,200
| +9% | +$19.3K | ﹤0.01% | 3838 |
|
|
2013
Q3 | $213K | Buy |
+12,775
| New | +$213K | ﹤0.01% | 3809 |
|